help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Setaro, J. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Setaro, J. F.
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 6 3804
Copyright © 2005 by The Endocrine Society


Letter to the editor

Authors’ Response: Pheochromocytoma, Steroids, & Myocardial Infarction

John F. Setaro

Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut 06520

Address correspondence to: John F. Setaro, M.D., Yale University School of Medicine, Section of Cardiovascular Medicine, 333 Cedar Street, P.O. Box 208017, New Haven, Connecticut 06520. E-mail: john.setaro{at}yale.edu.

To the editor:

We thank Dr. Balkin (1) for his thoughtful letter, in which he offers an intelligent and plausible alternative explanation for our patient’s labile clinical course (2). However, we would like to comment on one specific point raised in his letter. Although it seems true that in states of adrenal cortical insufficiency, subnormal epinephrine responses are not corrected by exogenous glucocorticoids (3), the effect of supraphysiological glucocorticoid exposure on adrenal medullary function is less clear. In our patient, who received 6 mg dexamethasone daily, glucocorticoid levels (even in the adrenal medulla) were presumably nearly 10-fold higher than normal. The local threshold level of glucocorticoid required to sustain adrenal medullary epinephrine production is worthy of further study and discussion.

Received April 7, 2005.

References

  1. Balkin MS 2005 Pheochromocytoma, steroids, & myocardial infarction. J Clin Endocrinol Metab 90:3803–3804 (Letter)[Free Full Text]
  2. Brown H, Goldberg PA, Selter JG, Cabin HS, Marieb NJ, Udelsman R, Setaro JF 2005 Clinical case seminar: hemorrhagic pheochromocytoma associated with systemic corticosteroid therapy and presenting as myocardial infarction with severe hypertension. J Clin Endocrinol Metab 90:563–569[Abstract/Free Full Text]
  3. Stewart PM 2004 Adrenal replacement therapy: time for an inward look to the medulla? J Clin Endocrinol Metab 89:3677–3678[Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Setaro, J. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Setaro, J. F.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals